Starget Pharma

Starget PharmaStarget Pharma
Starget Pharma

Starget Pharma

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Website
DR 14Speed 712019Inactive21
Rate
Advertise here

About

Starget Pharma develops Smart Targeted Radioligands (STRs) for precision oncology of hard-to-heal cancers. Their AI-driven peptide-based discovery engine rapidly identifies radioligands that deliver high-energy radiation precisely to tumoral and metastatic cancer cells while sparing healthy tissues. This technology aims to accelerate the discovery and development of novel, targeted peptide radioligands for a broad range of cancers, offering new hope to patients.
Frequently asked

What does Starget Pharma do?

Starget Pharma develops Smart Targeted Radioligands (STRs) for precision oncology of hard-to-heal cancers. Their AI-driven peptide-based discovery engine rapidly identifies radioligands that deliver high-energy radiation precisely to tumoral and metastatic cancer cells while sparing healthy tissues. This technology aims to accelerate the discovery and development of novel, targeted peptide radioligands for a broad range of cancers, offering new hope to patients.

What is Starget Pharma's revenue?

StartupHub estimates Starget Pharma's annual revenue at $6.2M (range $4.0M to $9.9M, 67% confidence), based on comparable companies in the sector.

What is Starget Pharma's valuation?

StartupHub estimates Starget Pharma's effective valuation at $15.5M (range $10.8M to $20.1M, 35% confidence), based on comparable companies in the sector.

How much funding has Starget Pharma raised?

Starget Pharma has raised a total of $15M in funding. The most recent round on record is Series B.

When was Starget Pharma founded?

Starget Pharma was founded in 2019.

What industry does Starget Pharma operate in?

Starget Pharma operates in Healthcare, Oncology, Life Sciences, Biotech, MedTech, HealthTech.

How many employees does Starget Pharma have?

Starget Pharma has approximately 21 people on record.

What is Starget Pharma's current status?

Starget Pharma's current operating status is: Inactive.

HEADCOUNT
21
DOMAIN RATING
14
New entrants in Life Sciences
Last 90 days
7
New entrants
2.3
Per month
0.5
Per week
Most recent
Galatek

Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.

Jul 13
Raven4batchrecords

Digital batch record software for pharmaceutical and biotech manufacturing.

Jul 9
Biotalent

Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.

Jun 14
Maasbiolabs

AI-powered platform accelerating biological research and drug discovery.

Jun 11
Healthark

A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.

May 27
Lseconnect

Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.

May 26

An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.